Introducing a probabilistic definition of the target in a robust treatment planning framework
Creators
- 1. Université Catholique de Louvain, Institut de Recherche Expérimentale et Clinique (IREC), Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), Avenue Hippocrate 54—Box B1.54.07, B-1200 Brussels (Belgium)
Description
The 'clinical target distribution' (CTD) has recently been introduced as a promising alternative to the binary clinical target volume (CTV). However, a comprehensive study that considers the CTD, together with geometric treatment uncertainties, was lacking. Because the CTD is inherently a probabilistic concept, this study proposes a fully probabilistic approach that integrates the CTD directly in a robust treatment planning framework. First, the CTD is derived from a reported microscopic tumor infiltration model such that it explicitly features the probability of tumor cell presence in its target definition. Second, two probabilistic robust optimization methods are proposed that evaluate CTD coverage under uncertainty. The first method minimizes the expected-value (EV) over the uncertainty scenarios and the second method minimizes the sum of the expected value and standard deviation (EV-SD), thereby penalizing the spread of the objectives from the mean. Both EV and EV-SD methods introduce the CTD in the objective function by using weighting factors that represent the probability of tumor presence. The probabilistic methods are compared to a conventional worst-case approach that uses the CTV in a worst-case optimization algorithm. To evaluate the treatment plans, a scenario-based evaluation strategy is implemented that combines the effects of microscopic tumor infiltrations with the other geometric uncertainties. The methods are tested for five lung tumor patients, treated with intensity-modulated proton therapy. The results indicate that for the studied patient cases, the probabilistic methods favor the reduction of the esophagus dose but compensate by increasing the high-dose region in a low conflicting organ such as the lung. These results show that a fully probabilistic approach has the potential to obtain clinical benefits when tumor infiltration uncertainties are taken into account directly in the treatment planning process. (paper)
Availability note (English)
Available from http://dx.doi.org/10.1088/1361-6560/ac1265Additional details
Identifiers
Publishing Information
- Journal Title
- Physics in Medicine and Biology
- Journal Volume
- 66
- Journal Issue
- 15
- Journal Page Range
- [15 p.]
- ISSN
- 0031-9155
- CODEN
- PHMBA7
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53063606
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ESOPHAGUS; LUNGS; NEOPLASMS; PROBABILISTIC ESTIMATION; PROTON BEAMS; RADIOTHERAPY; TUMOR CELLS
- Descriptors DEC
- ANIMAL CELLS; BEAMS; BODY; CALCULATION METHODS; DIGESTIVE SYSTEM; DISEASES; MEDICINE; NUCLEAR MEDICINE; NUCLEON BEAMS; ORGANS; PARTICLE BEAMS; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY